PTX-100 is now in a Phase 2a trial for cutaneous T-cell lymphoma, a rare form of blood cancer with limited treatment options and poor survival rates in advanced disease.
Copper smelter economics are shifting as capacity outpaces supply, with Minrex potentially benefiting from a gold-silver concentrate at Tlamino in Serbia.